Isometric diagram of two distinct G-protein-coupled receptors, one teal and one amber, side by side in a membrane cross-section, representing the GHRH receptor and the GHS receptor
Mindful Research

GHRH Analogs vs GH Secretagogues: Two Receptor Classes in In-Vitro Research

Updated By: Mindful Research Team2 min read

Key takeaways

  • GHRH analogs act at the GHRH receptor; GH secretagogues act at the GHS (ghrelin) receptor.
  • The two receptors are distinct GPCRs, so compounds are classed by which one they engage.
  • Sermorelin and tesamorelin are GHRH-analog reference compounds; ipamorelin is a GHS reference compound.
  • Receptor assays use cell models expressing the matching receptor.
  • All compounds are for in vitro research use only.

Growth-hormone-related reference compounds fall into two families defined by the receptor they engage: GHRH analogs act at the GHRH receptor, while growth-hormone secretagogues act at the GHS receptor (the ghrelin receptor). This guide separates the two classes for in-vitro work.

Two receptors, two families

The GHRH receptor and the GHS receptor (GHS-R1a, the ghrelin receptor) are distinct G-protein-coupled receptors. A compound is classed by which one it engages, and the two families are studied as separate tools.

GHRH-analog reference compounds

GHRH analogs are peptides modeled on growth-hormone-releasing hormone. In receptor assays they engage the GHRH receptor; sermorelin and tesamorelin are examples used as reference compounds, as is CJC-1295 no DAC (Modified GRF(1-29)).

GH secretagogue reference compounds

Growth-hormone secretagogues engage the GHS receptor instead. Ipamorelin is a frequently studied example in this class. When one compound from each family is studied in the same cell, the design question is covered in why pair a GHRH analog with a GHRP?

Why the distinction matters in vitro

Because the two classes hit different receptors, researchers choose cell models expressing the matching receptor and compare compounds within a class, not across classes, to keep the readout interpretable.

Related research guides

Research-use note

All compounds referenced are supplied for in vitro laboratory research use only. They are not for human or animal use.

Related research: Sermorelin.

Frequently asked questions

What are the two receptor classes?

The GHRH receptor and the GHS receptor (the ghrelin receptor, GHS-R1a) are two distinct G-protein-coupled receptors that define the two families.

What is a GHRH analog?

A peptide modeled on growth-hormone-releasing hormone that engages the GHRH receptor, such as sermorelin or tesamorelin. View Sermorelin

What is a GH secretagogue?

A compound that engages the GHS (ghrelin) receptor, such as ipamorelin. View Ipamorelin

Why keep the classes separate in vitro?

Because they act at different receptors, researchers use matching cell models and compare within a class to keep readouts interpretable.

Research use only?

Yes, in vitro laboratory research use only.

Continue reading

Vial of blue copper-complex lyophilized peptide powder in a cold-storage block, representing KLOW 80 mg handling and stabilityKLOW 80 mg: Copper-Complex Blue Lyophilized Powder, Handling, Stability and Stock Concentration Math The KLOW 80 mg vial is a pale-blue lyophilized powder because one of its four components, GHK-Cu, is a copper(II) complex; reconstituted... Researcher in a lab coat checking a vial of blue peptide blend powder against a four-peak analytical readoutSourcing KLOW as a Research Material: Per-Component COA and Purity Sourcing KLOW as a research material means obtaining, in one Certificate of Analysis, the identity and purity data for all four of... Two vials of blue peptide blend powder side by side, one with an extra tripeptide render, representing GLOW versus KLOWGLOW vs KLOW: What KPV Adds to the Blend (Composition Comparison) The difference between GLOW and KLOW is one component: KLOW adds 10 mg of the tripeptide KPV (Lys-Pro-Val, CAS 67727-97-3) to GLOW's...